(Q40511451)

21 September 2017

title

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections (English)

1 reference

21 September 2017

0 references

Orthoebolavirus zairense

0 references

0 references

1 reference

6

Sina Bavari

1 reference

21 September 2017

4

Alan Schmaljohn

1 reference

21 September 2017

5

M Javad Aman

1 reference

21 September 2017

2

Kelly L Warfield

1 reference

21 September 2017

3

Diane L Negley

1 reference

21 September 2017

1

Dana L Swenson

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

21 September 2017

1 reference

21 September 2017

volume

23

1 reference

21 September 2017

issue

23

1 reference

21 September 2017

page(s)

3033-3042

1 reference

Ebola virus: from discovery to vaccine

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Marburg-virus disease in Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Ebola virus pathogenesis: implications for vaccines and therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Vaccine research efforts for filoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Marburg virus vaccines: comparing classical and new approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Development of a preventive vaccine for Ebola virus infection in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Vaccine for AIDS and Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Overcoming immunity to a viral vaccine by DNA priming before vector boosting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Ebola virus-like particles protect from lethal Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Inactivated vaccine for Ebola virus efficacious in guineapig model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Pathogenesis of experimental Ebola virus infection in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Epitopes involved in antibody-mediated protection from Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Molecular mechanisms of filovirus cellular trafficking.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Immunization for Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Evaluation in nonhuman primates of vaccines against Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Inactivated Marburg virus elicits a nonprotective immune response in Rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Marburg and Ebola viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

Molecular biology and evolution of filoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

inferred from DOI database lookup

7 January 2021

based on heuristic

Plaque assay for Ebola virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.070

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.11.070

1 reference

21 September 2017

1 reference